Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice

American Journal of Pathology

Volumn 156, Issue 3, 2000, Pages 951-964

  Tesseur, I ^a   Van Dorpe, J ^a   Spittaels, K ^a   Van den Haute, C ^a   Moechars, D ^a   Van Leuven, F ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; BRAIN PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTOSIS; CELLULAR DISTRIBUTION; CYTOSKELETON; HIPPOCAMPUS; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK FACTOR; TRANSGENIC MOUSE;

EID: 0033889344     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64963-2     Document Type: Article

References (82)

1. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
2. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease
3. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant
4. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease
5. A beta-peptide length and apolipoprorein E genotype in Alzheimer's disease
6. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes
7. The -491 A/T polymorphism of the apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease
8. A new polymorphism in the ApoE promoter associated with risk of developing Alzheimer's disease
9. A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia
10. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene
11. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease
12. ApoE genotype, and survival from intracerebral haemorrhage
13. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing
14. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease
15. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid β-protein following head injury
16. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele
17. Preliminary report of a genetic basis for cognitive decline after cardiac operations
18. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease, and in age-matched controls
19. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease
20. Specific regional transcription of apolipoprotein E in human brain neurons
21. Regionally specific neuronal expression of human APOE gene in transgenic mice
22. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: Human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice
23. Cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic mice
24. Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology
25. Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE
26. ApoE synthesis in human neuroblastoma cells
27. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat
28. Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia
29. Cystatin C, and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus
30. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning
31. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins
32. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central netvous system-derived neuronal cell line
33. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymedzation
34. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
35. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth
36. Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures
37. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth, and is a ligand for the low density lipoprotein receptor-related protein
38. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: Implications for Alzheimer's disease
39. Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice
40. GFAP promoter directs astrocyte-specific expression in transgenic mice
41. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
42. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs
43. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model
44. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: In vivo companson of distinct GFAP-lacZ transgenes
45. Targeted inactivation of the mouse α 2-macroglobulin gene
46. Expression of the Thy-1 glycoprotein gene by DNA-mediated gene transfer
47. The mouse Thy-1.2 glycoprotein gene: Complete sequence and identification of an Unusual promoter
48. Thy-1, the enigmatic extrovert on the neuronal surface
49. Expression of Thy-1/lacZ fusion genes n the CNS of transgenic mice
50. Regulation of Thy-1 gene expression in transgenic mice
51. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
52. Expression of X-linked genes in androgenetic, gynogenetic, and normal mouse preimplantation embryos
53. Age-related phosphorylation and fragmentation events influence the distribution profiles of distinct tau isoforms in mouse brain
54. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex
55. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females
56. Phosphorylation of tau in apolipoprotein E-deficient mice
57. Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment
58. Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E
59. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
60. Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles
61. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
62. Neurodegenerative changes including altered tau phosphorylation and neurofilament immunore-activity in mice transgenic for the serine/threonine kinase Mos
63. Cytoskeletal changes in the brains of mice lacking calcineurin A α
64. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
65. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
66. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
67. Staging of Alzheimer's disease-related neurofibrillary changes
68. Evolution of the neuropathology of Alzheimer's disease
69. Reactive astrocytes: Cellular and molecular cues to biological function
70. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
71. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familia Alzheimer disease
72. Apolipoprotefn E: A pathological chaperone protein in patients with cerebral and systemic amyloid
73. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype
74. A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprorein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic
75. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region
76. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease
77. A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease
78. The -491 AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease
79. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele
80. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity
81. Neurotoxicity of the 22 kd thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated
82. Neurite degeneration elicited by apolipoprotein E peptides